How CRISPR-Cas9 Gene Editing Is Revolutionizing Medical Research
As one of the latest advancements in genome editing, CRISPR-Cas9 has provided deep insights for geneticists and scientists who are … Keep Reading
CPhI series reporting successful first half to 2019
The CPhI global pharma event series – part of Informa Market’s Health & Nutrition business – continues to surge ahead in 2019 with its global editions securing increased visitor and exhibitor numbers. The events’ successes have harnessed the trend towards increased outsourcing in the pharma supply chain and has directly contributed to an increasingly global industry. Growth in the first half of this year has been particularly impressive at its Asian editions. At the start of the year, Pharmapack Europe…
You might be interested in
How CRISPR-Cas9 Gene Editing Is Revolutionizing Medical Research
As one of the latest advancements in genome editing, CRISPR-Cas9 has provided deep insights for geneticists and scientists who are studying genetic mutations and disorders. Through CRISPR technology, experts can look at the functionality of gene mutations as well as the different pathways they take throughout cells. The method, which was adapted from the natural processes of specific types of bacteria, is introducing a more efficient and inexpensive way to edit genomes. The CRISPR Difference What makes the CRISPR-Cas9 system…
30 million diabetics in US deserve to know their future kidney disease status
Proteomics International (PILL; ASX: PIQ) will be at the 2019 BIO International Convention in Philadelphia (stand #2349) preparing for the US roll-out of PromarkerD, a blood test that can diagnose and predict whether a healthy patient will develop diabetic kidney disease. “PromarkerD is world-beating technology and needs to get into the hands of specialists and physicians to stem the tsunami of kidney disease which is causing over 40,000 deaths per year in the US, with related healthcare spending exceeding US$100…